Methenamine is an antibiotic that eliminates bacteria, which cause urinary tract infections (UTIs). It is prescribed in chronic infections and to prevent recurrence of infections on a long-term basis. This antibiotic is not prescribed for fever, cold, flu, or other viral infections.
It works as a urinary antiseptic, and it safely produces formaldehyde to inhibit bacterial growth while preventing bacterial resistance. It significantly decreases the recurrence of bacteriuria up to 25 months when compared with placebo. In older adults, urinary tract infections can lead to severe and life-threatening infections. Physiological factors that change with age are responsible for the increased frequency of UTI recurrence in older adults.
COVID-19 Impact Analysis
After the COVID-19 virus outbreak in December 2019, the World Health Organization announced it a public health emergency. The disease has spread to over 100 countries and affected lives around the globe. Particularly the global manufacturing, pharmaceutical, tourism, and financial markets have been hit hard. The outbreak of the pandemic has added risk factors to the already weak growth of the world economy. However, the descending pressure on the world economy that once showed signs of improvement in the previous period has improved again.
Furthermore, the high costs associated with the installation and maintenance of the machines are also a factor that may hinder the revenue growth of the global methenamine market throughout this forecast period.
Top Impacting Factors
- The methenamine market is leading due to the growth in the prevalence of 50 to 60%reported cases of urinary tract infections of in adult women.
- The growth of the methenamine market is further driven by rise in geriatric population. Furthermore, the heightened public awareness about the benefits of methenamine and severe infections caused by UTI are also leaving a positive impact on the methenamine market.
- In addition, the increasing R&D expenditure by pharmaceutical companies to treat UTI is anticipated to surge the demand for methenamine.
- However, no specific guideline &lack of evidence for the treatment &prevention of recurrent UTI in older patients are expected to restrict the market growth.
- There are very limited key players for over-the-counter methenamine tablets, which is an opportunity for the growth of the market.
Market Trends
New Product Launches to Flourish the Market
- In July 2019, Bryant Ranch Prepack (BRP) Pharmaceuticals, one of the leaders in the physician-dispensed prescription industry, launched a branded methenamine mandelate tablet. This tablet is film-coated and available in 500mg dose.
- In December 2020, AvPAK Pharmaceutical and Ingenus Pharmaceuticals, LLC launched the generic oral version of methenamine Hippurate tablet in 1000mg dose.
- In September 2020, iNova Pharmaceuticals (Singapore) Pte Ltd. (incorporated in Singapore) Malaysia Branch marketed the first over-the-counter Hiprex 1gm oral tablet.
Surge in Global Methenamine Market
Many leading players in the global methenamine market are concentrating on the extension of their business operations in promising regions. In addition, companies in the global methenamine market are plotting strategies for product modernization and development of product portfolio not only by venture capital but also by mergers and acquisitions.
Key Benefits of the Report
- This study presents the analytical depiction of the methenamine market along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the methenamine market share.
- The current market is quantitatively analyzed to highlight the growth scenario of the methenamine market.
- Porter’s five forces analysis illustrates the potency of buyers and suppliers in the market.
- The report provides a detailed analysis of the methenamine market based on the competitive intensity and how the competition will take shape in coming years.
Questions Answered in the Methenamine Report
- Which are the leading players active in the methenamine market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What future projections would help in taking further strategic steps?
- What is "methenamine”?
- What is "methenamine" market prediction in the future?
- Who are the leading global players in the "methenamine “market?
- What are the current trends and predicted trends?
- What are the key benefits of the "methenamine” market report?
Methenamine Market, by Product Type Report Highlights
| Aspects | Details |
 By Product Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Runhua Chemical, Shengxuelong Chemical, COPENOR, Guangzhou Hanpu Pharmaceutical, Simalin, Xudong Chemical, Shchekinoazot JSC, Feno Resinas, Sina Chemical, Linze Chemical |
Loading Table Of Content...
